# Traeger, Inc.: financial statements, quarterly

COOK · NYSE · CIK 1857853 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cook.md) · [Financials](/companies/cook/financials.md) · [Filings](/companies/cook/filings.md) · [Insiders](/companies/cook/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cook/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [118](/filings/0001857853-24-000117.md) | [163 d](/filings/0001628280-26-015450.md) | [145](/filings/0001857853-25-000052.md) | [168](/filings/0001857853-25-000097.md) | [122](/filings/0001628280-25-049776.md) | [169 d](/filings/0001628280-26-015450.md) | [143](/filings/0001628280-26-033681.md) | [145](/filings/0001628280-26-053737.md) | [125](/filings/0001628280-25-049776.md) | [145 d](/filings/0001628280-26-015450.md) | [94.1](/filings/0001628280-26-033681.md) | [120](/filings/0001628280-26-053737.md) |
| Cost of revenue | $m | [73.1](/filings/0001857853-24-000117.md) | [103 d](/filings/0001628280-26-015450.md) | [82.4](/filings/0001857853-25-000052.md) | [96.1](/filings/0001857853-25-000097.md) | [70.4](/filings/0001628280-25-049776.md) | [99.7 d](/filings/0001628280-26-015450.md) | [83.8](/filings/0001628280-26-033681.md) | [88.5](/filings/0001628280-26-053737.md) | [76.9](/filings/0001628280-25-049776.md) | [91.0 d](/filings/0001628280-26-015450.md) | [51.1](/filings/0001628280-26-033681.md) | [72.7](/filings/0001628280-26-053737.md) |
| Gross profit | $m | [44.7](/filings/0001857853-24-000117.md) | [60.1 d](/filings/0001628280-26-015450.md) | [62.6](/filings/0001857853-25-000052.md) | [72.3](/filings/0001857853-25-000097.md) | [51.7](/filings/0001628280-25-049776.md) | [68.9 d](/filings/0001628280-26-015450.md) | [59.5](/filings/0001628280-26-033681.md) | [57.0](/filings/0001628280-26-053737.md) | [48.5](/filings/0001628280-25-049776.md) | [54.3 d](/filings/0001628280-26-015450.md) | [43.0](/filings/0001628280-26-033681.md) | [47.4](/filings/0001628280-26-053737.md) |
| Operating income | $m | [(12.9)](/filings/0001857853-24-000117.md) | [(11.7) d](/filings/0001628280-26-015450.md) | [(0.1)](/filings/0001857853-25-000052.md) | [4.8](/filings/0001857853-25-000097.md) | [(7.4)](/filings/0001628280-25-049776.md) | [(0.2) d](/filings/0001628280-26-015450.md) | [3.4](/filings/0001628280-26-033681.md) | [(6.1)](/filings/0001628280-26-053737.md) | [(83.4)](/filings/0001628280-25-049776.md) | [(11.7) d](/filings/0001628280-26-015450.md) | [(1.0)](/filings/0001628280-26-033681.md) | [(1.7)](/filings/0001628280-26-053737.md) |
| Interest expense | $m | [7.5](/filings/0001857853-23-000139.md) | [7.9 d](/filings/0001857853-24-000020.md) | [8.1](/filings/0001857853-24-000049.md) | [8.7](/filings/0001857853-24-000095.md) | [8.5](/filings/0001628280-25-049776.md) | [8.2 d](/filings/0001628280-26-015450.md) | [7.9](/filings/0001628280-26-033681.md) | [8.1](/filings/0001628280-26-053737.md) | [7.8](/filings/0001628280-25-049776.md) | [7.6 d](/filings/0001628280-26-015450.md) | [7.6](/filings/0001628280-26-033681.md) | [8.3](/filings/0001628280-26-053737.md) |
| Income tax | $m | [0.9](/filings/0001857853-24-000117.md) | [0.8 d](/filings/0001628280-26-015450.md) | [0.2](/filings/0001857853-25-000052.md) | [(0.0)](/filings/0001857853-25-000097.md) | [(0.1)](/filings/0001628280-25-049776.md) | [(2.0) d](/filings/0001628280-26-015450.md) | [(1.6)](/filings/0001628280-26-033681.md) | [(0.4)](/filings/0001628280-26-053737.md) | [(0.3)](/filings/0001628280-25-049776.md) | [(1.8) d](/filings/0001628280-26-015450.md) | [(0.3)](/filings/0001628280-26-033681.md) | [(0.9)](/filings/0001628280-26-053737.md) |
| Net income | $m | [(19.3)](/filings/0001857853-24-000117.md) | [(24.0) d](/filings/0001628280-26-015450.md) | [(4.7)](/filings/0001857853-25-000052.md) | [(2.6)](/filings/0001857853-25-000097.md) | [(19.8)](/filings/0001628280-25-049776.md) | [(7.0) d](/filings/0001628280-26-015450.md) | [(0.8)](/filings/0001628280-26-033681.md) | [(7.4)](/filings/0001628280-26-053737.md) | [(89.8)](/filings/0001628280-25-049776.md) | [(17.2) d](/filings/0001628280-26-015450.md) | [2.9](/filings/0001628280-26-033681.md) | [(8.6)](/filings/0001628280-26-053737.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001857853-24-000117.md) | not reported | [(0.04)](/filings/0001857853-25-000052.md) | [(0.02)](/filings/0001857853-25-000097.md) | [(0.15)](/filings/0001628280-25-049776.md) | not reported | [(0.30)](/filings/0001628280-26-033681.md) | [(2.77)](/filings/0001628280-26-053737.md) | [(0.67)](/filings/0001628280-25-049776.md) | not reported | [1.08](/filings/0001628280-26-033681.md) | [(3.12)](/filings/0001628280-26-053737.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0001857853-24-000117.md) | not reported | [(0.04)](/filings/0001857853-25-000052.md) | [(0.02)](/filings/0001857853-25-000097.md) | [(0.15)](/filings/0001628280-25-049776.md) | not reported | [(0.30)](/filings/0001628280-26-033681.md) | [(2.77)](/filings/0001628280-26-053737.md) | [(0.67)](/filings/0001628280-25-049776.md) | not reported | [1.08](/filings/0001628280-26-033681.md) | [(3.12)](/filings/0001628280-26-053737.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.3](/filings/0001857853-23-000139.md) | [29.9](/filings/0001857853-25-000018.md) | [23.6](/filings/0001857853-24-000049.md) | [18.0](/filings/0001857853-24-000095.md) | [16.9](/filings/0001857853-24-000117.md) | [15.0](/filings/0001628280-26-015450.md) | [12.0](/filings/0001857853-25-000052.md) | [10.3](/filings/0001857853-25-000097.md) | [5.9](/filings/0001628280-25-049776.md) | [19.6](/filings/0001628280-26-053737.md) | [33.7](/filings/0001628280-26-033681.md) | [59.7](/filings/0001628280-26-053737.md) |
| Current assets | $m | [199](/filings/0001857853-23-000139.md) | [216](/filings/0001857853-25-000018.md) | [231](/filings/0001857853-24-000049.md) | [225](/filings/0001857853-24-000095.md) | [217](/filings/0001857853-24-000117.md) | [243](/filings/0001628280-26-015450.md) | [253](/filings/0001857853-25-000052.md) | [220](/filings/0001857853-25-000097.md) | [216](/filings/0001628280-25-049776.md) | [215](/filings/0001628280-26-053737.md) | [214](/filings/0001628280-26-033681.md) | [222](/filings/0001628280-26-053737.md) |
| Total assets | $m | [837](/filings/0001857853-23-000139.md) | [861](/filings/0001857853-25-000018.md) | [862](/filings/0001857853-24-000049.md) | [842](/filings/0001857853-24-000095.md) | [818](/filings/0001857853-24-000117.md) | [831](/filings/0001628280-26-015450.md) | [826](/filings/0001857853-25-000052.md) | [781](/filings/0001857853-25-000097.md) | [690](/filings/0001628280-25-049776.md) | [676](/filings/0001628280-26-053737.md) | [662](/filings/0001628280-26-033681.md) | [655](/filings/0001628280-26-053737.md) |
| Current liabilities | $m | [108](/filings/0001857853-23-000139.md) | [134](/filings/0001857853-25-000018.md) | [133](/filings/0001857853-24-000049.md) | [110](/filings/0001857853-24-000095.md) | [104](/filings/0001857853-24-000117.md) | [122](/filings/0001628280-26-015450.md) | [115](/filings/0001857853-25-000052.md) | [75.6](/filings/0001857853-25-000097.md) | [73.0](/filings/0001628280-25-049776.md) | [80.1](/filings/0001628280-26-053737.md) | [63.0](/filings/0001628280-26-033681.md) | [63.6](/filings/0001628280-26-053737.md) |
| Total liabilities | $m | [525](/filings/0001857853-23-000139.md) | [569](/filings/0001857853-25-000018.md) | [567](/filings/0001857853-24-000049.md) | [545](/filings/0001857853-24-000095.md) | [538](/filings/0001857853-24-000117.md) | [554](/filings/0001628280-26-015450.md) | [546](/filings/0001857853-25-000052.md) | [506](/filings/0001857853-25-000097.md) | [503](/filings/0001628280-25-049776.md) | [505](/filings/0001628280-26-053737.md) | [487](/filings/0001628280-26-033681.md) | [487](/filings/0001628280-26-053737.md) |
| Long-term debt | $m | not reported | [397](/filings/0001857853-25-000018.md) | not reported | not reported | not reported | [398](/filings/0001628280-26-015450.md) | not reported | not reported | not reported | [400](/filings/0001628280-26-015450.md) | not reported | not reported |
| Current portion of debt | $m | not reported | [0.3](/filings/0001857853-25-000018.md) | not reported | not reported | not reported | [0.3](/filings/0001628280-26-015450.md) | not reported | not reported | not reported | [0.3](/filings/0001628280-26-015450.md) | not reported | not reported |
| Shareholders' equity | $m | [312](/filings/0001857853-24-000117.md) | [291](/filings/0001628280-26-015450.md) | [295](/filings/0001857853-25-000097.md) | [297](/filings/0001628280-25-049776.md) | [280](/filings/0001628280-25-049776.md) | [276](/filings/0001628280-26-053737.md) | [280](/filings/0001628280-26-053737.md) | [274](/filings/0001628280-26-053737.md) | [186](/filings/0001628280-25-049776.md) | [171](/filings/0001628280-26-053737.md) | [175](/filings/0001628280-26-053737.md) | [167](/filings/0001628280-26-053737.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.5 d](/filings/0001857853-24-000117.md) | [19.7 d](/filings/0001628280-26-015450.md) | [(12.6)](/filings/0001857853-25-000052.md) | [13.9 d](/filings/0001857853-25-000097.md) | [15.1 d](/filings/0001628280-25-049776.md) | [7.5 d](/filings/0001628280-26-015450.md) | [(20.8)](/filings/0001628280-26-033681.md) | [18.3 d](/filings/0001628280-26-053737.md) | [7.6 d](/filings/0001628280-25-049776.md) | [15.5 d](/filings/0001628280-26-015450.md) | [17.9](/filings/0001628280-26-033681.md) | [27.1 d](/filings/0001628280-26-053737.md) |
| Capital expenditure | $m | [6.8 d](/filings/0001857853-24-000117.md) | [4.3 d](/filings/0001628280-26-015450.md) | [5.7](/filings/0001857853-25-000052.md) | [2.1 d](/filings/0001857853-25-000097.md) | [2.3 d](/filings/0001628280-25-049776.md) | [2.0 d](/filings/0001628280-26-015450.md) | [1.8](/filings/0001628280-26-033681.md) | [2.6 d](/filings/0001628280-26-053737.md) | [1.2 d](/filings/0001628280-25-049776.md) | [1.3 d](/filings/0001628280-26-015450.md) | [3.4](/filings/0001628280-26-033681.md) | [0.6 d](/filings/0001628280-26-053737.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [120](/filings/0001857853-23-000139.md) | [123](/filings/0001857853-24-000049.md) | [123](/filings/0001857853-24-000095.md) | [124](/filings/0001857853-24-000117.md) | [125](/filings/0001857853-25-000052.md) | [127](/filings/0001857853-25-000097.md) | [128](/filings/0001628280-25-049776.md) | [2.6](/filings/0001628280-26-033681.md) | [2.7](/filings/0001628280-26-053737.md) | [134](/filings/0001628280-25-049776.md) | [2.7](/filings/0001628280-26-033681.md) | [2.7](/filings/0001628280-26-053737.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,798,224 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053737.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.